PROGRAM AGENDA
The objective of the Update on Clinical Topics in Antiretroviral Therapy workshop is to update and review the latest practices in the field of antiretroviral treatment from a theoretical, practical and interactive perspective and it is aimed at an audience of HIV and infectious diseases healthcare professionals and researchers.
Thursday 8th October 2020 | |||
13.45-14:45 | Registration and lunch | Organizing committee | |
14:45- 15.00 | Welcome | J. M. Llibre | |
Block 1. HIV and ARVs evolution | Chair: Franco Maggiolo | ||
15.00 – 15.30 | The HIV epidemiology in Europe | Teymur Noori | |
15.30-16.00 | Update on ART, the era of excellence | Joseph J Eron | |
16.00-16.30 | COVID 19: Lessons learnt | Laura Waters | |
16.30- 17.oo | Overall discussion | ||
17.00-17.30 | Coffee break | ||
17.30 – 18.45 | Industry Round table: where are we headed | International Medical Department Representatives from Viiv (Max Lataillade, TBC), MSD (Fabien Sordet, TBC), Gilead (Cal Cohen) and Janssen (TBD). | |
18.45-19.00 | Overall discussion | ||
19.00-21.00 | Dinner reception |
Friday 9th October 2020 | ||||
9.00- 11.00 | INTERACTIVE SESSIONS
Clinical cases discussion – Break-out session in 2 groups Topics: Pregnant women, drug resistance, STIs in MSM and Aging- Comorbidities |
Chair: Chloe Orkin/ JM. Llibre. Franco Maggiolo, Federico Garcia, Adria Curran, Ignacio Bernardino. | ||
11.00-11.30 | Coffee break | |||
Block 2. Towards the elimination of HIV transmission | Chair: JM Llibre | |||
11.30–12.00 | Clinical implications of HIV resistance | Jürgen Rockstroh | ||
12.00–12.30 | PrEP finally here: how to proceed | Pep Coll | ||
12.30–13.00 | New options for highly treatment-experienced subjects | Jade Ghosn | ||
13.00-13.30 | Overall discussion | |||
13.30–14.00 | Lunch | |||
Block 3. Really getting rid of toxicities? | Chair: J. M. Llibre | |||
14.00-14.30 | Debate: Weight gain and obesity, a new problem? Absolutely/Not yet | Chloe Orkin, Pere Domingo | ||
14.30-15.00 | From NAFLD to NASH | Maud Lemoine (TBC) | ||
15.00-15.30 | Overall discussion | |||
15:30 | Closing remarks | B. Clotet |